Expert Opinion on Drug Discovery

Journal Title

Expert Opinion on Drug Discovery

EXPERT OPIN DRUG DIS

ISSN / eISSN

1746-0441 / 1746-045X

Aims and Scope

Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The Editors welcome:

Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology
Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug
The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.

Subject Area

PHARMACOLOGY & PHARMACY

CiteScore

10.70 View Trend

CiteScore Ranking

Category	Quartile	Rank
Pharmacology, Toxicology and Pharmaceutics - Drug Discovery	Q1	#18/156

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
PHARMACOLOGY & PHARMACY - SCIE	Q1

H-index

50

Country/Area of Publication

ENGLAND

Publisher

Informa Healthcare

Publication Frequency

Bimonthly

Year Publication Started

2006

Annual Article Volume

89

Open Access

NO

Contact

INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ